Clearside Biomedical Inc. (CLSD)

6.97 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 6.97

Price Open 6.83

Volume: 222,804

Avg Volume: 254,145

Market Cap: 223.21M

P/E Ratio -2.64

52 Wk Range 5.3-15.329



CLSD Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
31.4M
1.19M
5.72
3.78%

2018-07-13
31.32M
1.14M
3.55
3.63%

2018-06-29
31.32M
1.27M
1.95
4.06%

2018-06-15
31.38M
983,255
1.49
3.13%




CLSD Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-08
Q2 2018
BTO
-0.57 (4)
-0.65
-0.08

2018-05-09
Q1 2018
N/A
-0.57 (4)
-0.65
-0.08

2018-03-14
Q4 2017
BTO
-0.70 (4)
-0.65
-0.08

2018-03-13
Q4 2017
N/A
-0.69 (4)
-0.65
-0.08

News

Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q2 2018 Results - Earnings Call Transcript (2018-08-08 14:26 SeekingAlpha)

Clearside Biomedical, Inc. (CLSD) Q2 2018 Earnings Conference Call August 8, 2018 08:30 AM ET Executives Stephen Kilmer - Investor Relations Daniel White - Chief Executive Officer Glen Noronha - Chief Scientific Officer Charlie Deignan - Chief Financial Officer Brion Raymond …

 

Clearside Biomedical misses by $0.07 (2018-08-08 07:03 SeekingAlpha)

Clearside Biomedical (NASDAQ: CLSD ): Q2 EPS of -$0.65 misses by $0.07 . More news on: Clearside Biomedical, Earnings news and commentary, Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 32.02M

Top 15 Institution Percent: 65.20

Price To Sales: 1035.45

Price To Book: 3.26

Revenue: 155000

Gross Profit: N/A

Cash: 52.63M

Debt: 7.90M

Return On Assets: -92.23

Return On Equity: -119.24

Profit Margin: N/A

Price History

Beta: -6.86

50-day Moving Avg: 9.52

200-day Moving Avg: 9.00

YTD Change: -3.06

5-day Change: -8.17

1-month Change: -34.43

3-month Change: -42.73

6-month Change: 8.23

1-year Change: -1.55

Revenue Per Share: 0.00

Revenue Per Employee: 4559.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Clearside Biomedical Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.clearsidebio.com

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye. Its product candidates focuses on diseases affecting the retina.